{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:43:28Z","timestamp":1792683808225,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR129463"],"award-info":[{"award-number":["NIHR129463"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["10103153-ARISTOTELES"],"award-info":[{"award-number":["10103153-ARISTOTELES"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/6\/34223"],"award-info":[{"award-number":["AA\/18\/6\/34223"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.hrthm.2025.05.021","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:19:01Z","timestamp":1747621141000},"page":"44-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Ablation of atrial fibrillation and risk of stroke: A meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-9883","authenticated-orcid":false,"given":"Rui","family":"Providencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Creta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Kukendrarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapa","family":"Kanagaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal M.","family":"Farkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Cappato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.05.021_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.05.021_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.hrthm.2025.05.021_bib3","article-title":"Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide study of 5.6 million individuals","volume":"7","author":"Chung","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hrthm.2025.05.021_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1747-4949.2011.00706.x","article-title":"Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke","volume":"7","author":"Henriksson","year":"2012","journal-title":"Int J Stroke"},{"key":"10.1016\/j.hrthm.2025.05.021_bib5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.05.021_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.05.021_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.021_bib9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib10","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.recesp.2021.07.012","article-title":"Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018","volume":"75","author":"D\u00edaz-Guzm\u00e1n","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.hrthm.2025.05.021_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib15","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib16","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1161\/STROKEAHA.119.026890","article-title":"Atrial fibrillation ablation and reduction of stroke events: understanding the paradoxical lack of evidence","volume":"50","author":"Barra","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.05.021_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Ha\u00efssaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib18","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2023.03.418","article-title":"Procedure-related complications of catheter ablation for atrial fibrillation","volume":"81","author":"Benali","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib19","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.05.021_bib20","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"Higgins","year":"2024"},{"key":"10.1016\/j.hrthm.2025.05.021_bib21","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.05.021_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.05.021_bib23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/europace\/euac253","article-title":"Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial","volume":"25","author":"Kanagaratnam","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.05.021_bib25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.05.021_bib26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.021_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.05.021_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.05.021_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/europace\/euaa356","article-title":"Long-term observation of catheter ablation vs. pharmacotherapy in the management of persistent and long-standing persistent atrial fibrillation (CAPA study)","volume":"23","author":"Wu","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.05.021_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.05.021_bib34","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2016.10.037","article-title":"HotBalloon ablation of the pulmonary veins for paroxysmal AF: a multicenter randomized trial in Japan","volume":"68","author":"Sohara","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.05.021_bib37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12872-024-03920-0","article-title":"Comparison between catheter ablation versus permanent pacemaker implantation as an initial treatment for tachycardia-bradycardia syndrome patients: a prospective, randomized trial","volume":"24","author":"Cho","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hrthm.2025.05.021_bib38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2024.17921","article-title":"Pulmonary vein isolation vs sham intervention in symptomatic atrial fibrillation: the SHAM-PVI randomized clinical trial","volume":"332","author":"Dulai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.05.021_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ahj.2023.12.007","article-title":"Feasibility of double-blinded, placebo-controlled interventional study for assessing catheter ablation efficacy in persistent atrial fibrillation: insights from the ORBITA AF feasibility study","volume":"269","author":"Kanthasamy","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2025.05.021_bib40","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.3390\/jcm11195530","article-title":"Catheter ablation versus medical therapy of atrial fibrillation in patients with heart failure: an updated systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Magnocavallo","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2025.05.021_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/europace\/euac173","article-title":"Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials","volume":"25","author":"Simader","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.05.021_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10840-022-01365-z","article-title":"Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"65","author":"Deshpande","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib43","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/europace\/euab185","article-title":"Catheter ablation vs. antiarrhythmic drugs as \u2018first-line\u2019 initial therapy for atrial fibrillation: a pooled analysis of randomized data","volume":"23","author":"Chen","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.05.021_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10840-022-01451-2","article-title":"The impact of catheter ablation in patient\u2019s heart failure and atrial fibrillation: a meta-analysis of randomized clinical trials","volume":"66","author":"Sayed","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cjco.2020.03.013","article-title":"Health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis","volume":"2","author":"Allan","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.hrthm.2025.05.021_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40256-020-00435-9","article-title":"Long-Term outcomes and improvements in quality of life in patients with atrial fibrillation treated with catheter ablation vs. antiarrhythmic drugs","volume":"21","author":"Zheng","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hrthm.2025.05.021_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2018.03.068","article-title":"Association of catheter ablation for atrial fibrillation with mortality and stroke: a systematic review and meta-analysis","volume":"266","author":"Barra","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.021_bib49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.021_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023391","article-title":"Risks and benefits of early rhythm control in patients with acute strokes and atrial fibrillation: a multicenter, prospective, randomized study (the RAFAS Trial)","volume":"11","author":"Park","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.05.021_bib51","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.hrthm.2019.05.001","article-title":"Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 Study","volume":"16","author":"Osmancik","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.05.021_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.05.021_bib53","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.05.021_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125024452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125024452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:24:39Z","timestamp":1768418679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125024452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1547527125024452"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.021","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablation of atrial fibrillation and risk of stroke: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}